Peer-influenced content. Sources you trust. No registration required. This is HCN.
ReachMD
Explore the fascinating field of obesity management, where pharmacological treatments are combined with lifestyle modifications, to find out how doctors are reversing the trend in the fight against this epidemic on a global scale.
Endocrinology, Diabetes, Metabolism June 21st 2023
ScientiaCME
Engage in a comprehensive exploration of health disparities in clinical practice with this online CME course, and refine your skills to provide equitable care for all patients.
All Specialties June 14th 2023
myCME
Unfolding the Potentials of Anti-TROP2 ADC Therapy in Triple-Negative Breast Cancer Evolving therapeutic paradigms for triple-negative breast cancer (TNBC) are in focus, as esteemed experts highlight the use of novel anti-TROP2 antibody drug conjugates in an enlightening multidisciplinary tumor board.
Oncology, Medical June 8th 2023
Addressing the Underrecognized Issue of Male Osteoporosis: Evidence-based Strategies for Improved Detection and Management As the elderly population increases, osteoporosis in men, a condition often underdiagnosed and overlooked, is gaining significant prominence in public health. This self-learning activity enables healthcare professionals to gain critical insight into this issue and empower them with the latest evidence-based preventive and therapeutic strategies.
Clinical Pharmacology June 7th 2023
Dive into this CME program to grasp the latest C. difficile guidelines and implement treatment strategies effectively. This interactive CME program focuses on Clostridioides difficile, or C. difficile. As you know, this bacterium causes severe GI disturbances. Alarmingly, it impacts half a million Americans annually and burdens the healthcare system. Who is this for? Infectious disease physicians, gastroenterologists, hospitalists, intensivists, and all HCPs managing patients with C. difficile infection (CDI) will benefit greatly. Initially, the program offers a comprehensive review of CDI. It presents the epidemiology and pinpoints key risk factors. Moreover, it explains the underlying pathophysiology and outlines clinical features. Significantly, it emphasizes the disease’s burden and unveils diagnostic tools, including NAAT, GDH assay, and toxin tests. Following this, the program shifts to treatment strategies for CDI. It details procedures for various severity levels – mild, severe, fulminant, and recurrent. Concurrently, it underlines the common challenges in therapy decision-making. Importantly, it stresses the necessity of adhering to CDI guidelines and presents preventative measures. In the concluding section, participants receive practical patient cases. This allows the application of newfound knowledge directly. Afterward, it wraps up with a summary and a best practice recap. Upon completion, participants will grasp the burden […]
Family Medicine/General Practice May 24th 2023
Dig into the essence of diagnosing and managing bipolar depression to enrich your practice and improve patient well-being. Bipolar depression often presents an intricate diagnostic challenge due to its symptomatology, leading to delays in accurate diagnosis and frequent misdiagnoses as unipolar depression. Consequently, patients run the risk of suboptimal treatment, highlighting the need for more effective strategies in diagnosing and managing bipolar depression. Traditional therapeutic approaches, including monotherapy and adjunctive therapies, pose certain limitations. Notably, these treatments present side-effect concerns, adherence challenges, and substantial relapse rates. For optimal management of bipolar depression, healthcare providers should remain updated on the evolving landscape of newer pharmacological agents. This educational program underscores the importance of timely and accurate diagnosis of bipolar depression, covering both bipolar 1 and 2 depression. The emphasis is placed on differentiating these forms from unipolar depression, a crucial aspect for early recognition and accurate diagnosis. In terms of management, the program introduces evidence-based strategies, comparing monotherapies to adjunctive therapies. It also encourages providers to evaluate current treatment options for their clinical impact. By doing so, practitioners can ensure the development of patient-centered, evidence-based treatment plans. The successful application of these diagnostic and management strategies is expected to reduce the […]
Internal Medicine May 23rd 2023